A Look at Recent Transactions Shaping the Future of Healthcare
This week's article provides a summary of recent healthcare M&A news for March 4, 2025.
The healthcare industry is rapidly evolving, with the lines between the healthcare technology and services sectors blurring - creating the catalyst for innovation, transformation, and continued market activity. TripleTree's Healthcare M&A Weekly summarizes recent mergers, acquisitions, and investments shaping the future of healthcare.
To view previous healthcare M&A activity, please review last week's post: Healthcare M&A Weekly - February 26, 2025.
-
Autism Spectrum Interventions and Quality Behavior Solutions announced the two organizations are merging into one unified company – Alongside. This merger brings together two industry leaders in behavioral health, combining their strengths and premier services to create a more comprehensive and impactful support system for children, families, and communities navigating autism. Read more about the merger here.
-
Axess Family Services and Children’s Advantage announced that the two nonprofits are merging. Children’s Advantage provides behavioral healthcare services to children, adolescents and families. Axess offers comprehensive primary care and a wide range of community support programs. Learn more about the merger here.
-
bluebird bio, Inc. (NASDAQ: BLUE) entered into a definitive agreement to be acquired by funds managed by global investment firms Carlyle (NASDAQ: CG) and SK Capital Partners, LP (“SK Capital”) in collaboration with a team of highly experienced biotech executives. Click here for more on the acquisition.
-
CHG Healthcare, a staffing agency specializing in physician recruitment, has acquired CareerMD, a career management platform offering both digital and live events to help clinicians find their first job out of training. View the announcement here.
-
Cosette Pharmaceuticals, Inc., a U.S.-based pharmaceutical company, entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) for a total consideration of approximately $430M. Read more about the acquisition here.
-
Court Square Capital Partners closed on the sale of healthcare solutions company Knipper Health to Frazier Healthcare Partners. Court Square originally invested in the Company in October 2019. View the press release here.
-
EXA Capital announced the acquisition of PrecisionCare. Founded in New York, PrecisionCare provides a robust SaaS platform specializing in electronic health records (EHR) and care management solutions for the behavioral health and long-term care industries. Learn more about the acquisition here.
-
FullBloom, a child development platform providing academic, behavioral, and mental health interventions and support to K-12 schools, announced the acquisition of CharacterStrong, a national provider of multi-tiered school-based mental health solutions, including innovative proprietary curricula and supporting resources, as well as programming and training for K-12 educators. Click here for more on the acquisition.
-
KKR acquired a controlling stake in India healthcare provider Healthcare Global Enterprises for $400M. As part of the transaction, KKR will acquire up to 54% of equity in HCG from CVC Asia V at a purchase price of INR 445 per share. View the press release here.
-
Pacira BioSciences, Inc. (Nasdaq: PCRX), a provider of non-opioid pain therapies, acquired the remaining 81 percent equity stake of GQ Bio Therapeutics GmbH, a privately held biopharmaceutical company, for approximately $32M. Read more about the acquisition here.
-
Renovaro Biosciences Inc. (NASDAQ: RENB), a TechBio company focused on next-generation diagnostics, drug discovery, and genetically enhanced cancer therapies, announced a definitive agreement to merge with BioSymetrics, an artificial intelligence (AI)-driven drug discovery and biomarker identification company. Learn more about the merger here.
-
Solventum (NYSE: SOLV) announced it has entered into a definitive agreement to sell its Purification & Filtration business to Thermo Fisher Scientific Inc. (NYSE: TMO) for $4.1B. The transaction is intended to broaden Thermo Fisher's capabilities in the development and manufacturing of biologics. View the press release here.
-
Teleflex Incorporated (NYSE:TFX), a global provider of medical technologies, entered into a definitive agreement to acquire substantially all of the Vascular Intervention business of BIOTRONIK SE & Co. KG for an estimated cash payment on closing of approximately $790M. Read more about the acquisition here.
-
TPN.health (d.b.a Trusted Provider Network), a behavioral health network platform, has acquired All Counseling and their provider-patient matching technology, TheraMatch. TheraMatch is a digital referral solution designed to connect clients with the right behavioral health providers based on their unique clinical concerns and personal preferences. Learn more about the acquisition here.
Transactions outlined in this summary highlight some of the key trends shaping the future of healthcare. Get the latest industry news from TripleTree every week.
This is a partial list of transaction activity across the healthcare industry and is not intended to be a complete listing. Transaction information was identified from various sources and TripleTree may or may not have acted as the financial advisor for the transactions listed. All product names, logos and brands are property of their respective owners. All company, product and service names used in this communication are for identification purposes only. Use of these names, logos and brands does not imply endorsement.
